Symptomatic versus Endoscopic approach for the Diagnosis and Initial treatment of Gastroesophageal Reflux Disease using GerdQ
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2012
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms GMP
- Sponsors AstraZeneca
- 30 May 2011 New source identified and integrated.
- 27 May 2011 New trial record
- 01 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.